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Abstract
 
Both human cytomegaloviruses (HCMVs) and murine cytomegaloviruses (MCMVs) encode
multiple genes that interfere with antigen presentation by major histocompatibility complex
(MHC) class I, and thus protect infected targets from lysis by virus-specific cytotoxic T lym-
phocytes (CTLs). HCMV has been shown to encode four such genes and MCMV to encode
two. MCMV 
 
m152
 
 blocks the export of class I from a pre-Golgi compartment, and MCMV
 
m6
 
 directs class I to the lysosome for degradation. A third MCMV gene, 
 
m4
 
, encodes a glyco-
protein which is expressed at the cell surface in association with class I. Here we here show that
 
m4
 
 is a CTL-evasion gene which, unlike previously described immune-evasion genes, inhib-
ited CTLs without blocking class I surface expression. 
 
m152
 
 was necessary to block antigen
presentation to both K
 
b
 
- and D
 
b
 
-restricted CTL clones, while 
 
m4
 
 was necessary to block pre-
sentation only to K
 
b
 
-restricted clones. 
 
m152
 
 caused complete retention of D
 
b
 
, but only partial
retention of K
 
b
 
, in a pre-Golgi compartment. Thus, while 
 
m152
 
 effectively inhibited D
 
b
 
-
restricted CTLs, 
 
m4
 
 was required to completely inhibit K
 
b
 
-restricted CTLs. We propose that
cytomegaloviruses encode multiple immune-evasion genes in order to cope with the diversity
of class I molecules in outbred host populations.
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Introduction
 
CMVs, including human CMV (HCMV) and murine
CMV (MCMV), belong to the 
 
 
 
 subfamily of the 
 
Herpes-
viridae
 
, a family of large, double-stranded DNA viruses.
CMVs cause little pathology in normal host animals, but
cause severe disease when the immune system is compro-
mised. CMVs have developed intimate relationships with
the host immune systems which permit the viruses to es-
tablish latency and reactivate in the face of primed immune
responses. A number of mechanisms have been described
by which CMVs modulate host-immune responses; these
include chemokine receptor homologues and viral gene
products which interfere with the normal functions of T
cells and natural killer (NK)
 
*
 
 cells (1). In particular, both
HCMV and MCMV encode a number of gene products
which specifically interfere with the ability of infected cells
to present antigen to CD8
 
 
 
 CTLs (2, 3).
CD8
 
 
 
 T cells recognize a trimolecular complex, consist-
ing of class I heavy chain, 
 
 
 
2 microglobulin, and a short
antigenic peptide, which is assembled in the endoplasmic
reticulum (ER). In cells infected with HCMV, at least four
different viral gene products interfere with this assembly
(4): US6 blocks the peptide transporter associated with an-
tigen presentation (TAP, references 5–7); US3 prevents ex-
port to the Golgi (8, 9); and both US2 and US11 cause the
destruction of class I molecules by retrograde transport into
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the cytosol (10, 11). Similarly, at least three MCMV gene
products also alter class I assembly. m152/gp40 blocks
transport of class I molecules from the ER to the Golgi
(12–14); m6/gp48 binds to class I molecules and redirects
their transport into the lysosome for destruction (15); and
m4/gp34 binds class I in the ER, forming a complex which
is transported to the cell surface (16). Only 
 
m152
 
 and 
 
m6
 
have been previously shown to affect CTL function. There
is no sequence homology between these MCMV genes and
any mammalian or HCMV gene (17).
Although HCMV 
 
US3
 
 and MCMV 
 
m152
 
 both cause
class I retention, in HCMV-infected cells the dominant ef-
fect on class I is rapid degradation due to the actions of 
 
US2
 
and 
 
US11
 
 (18, 19). In contrast, in MCMV-infected cells,
class I is not degraded in the ER, but in fact accumulates in
a pre-Golgi compartment (12), and is degraded in the lyso-
some (15), or reaches the cell surface, sometimes in associa-
tion with m4/gp34 (16). Similarly, TAP function is
impaired by HCMV 
 
US6
 
, whereas TAP function is appar-
ently normal in MCMV-infected cells (unpublished data).
Finally, no molecule analogous to m4/gp34 has been ob-
served to coprecipitate with class I in HCMV-infected
cells. Thus, although there is no sequence homology be-
tween HCMV and MCMV genes that alter class I assem-
bly, both viruses still effectively inhibit class I antigen pre-
sentation through the use of multiple genes.
It seems likely that interference with CTL recognition
and the use of multiple genes to do so are both important
features of the CMV–host relationship. It is not clear why
both these viruses should carry a multiplicity of class
I–modulating genes, but a number of possible explanations
have been proposed. It has been suggested that individual
genes may augment the function of others, or that viruses
may require multiple different genes in order to interfere
with the function of diverse class I proteins in natural out-
bred host populations. This report provides evidence in
support of the latter hypothesis.
We have described previously the MCMV protein m4/
gp34, which binds to MHC class I but whose function was
not known. m4/gp34 is a 34-kD type 1 transmembrane gly-
coprotein, the product of the 
 
m4
 
 gene (16). m4/gp34 is ex-
pressed abundantly during the early phase of viral gene ex-
pression, and accumulates in the ER, where it binds to class I
molecules and forms a detergent-stable complex which is ex-
ported through the Golgi and to the cell surface. We specu-
lated previously that 
 
m4
 
 might serve to oppose the action of
 
m152
 
 by rescuing some class I molecules from retention,
thus protecting infected cells from NK cells which might
otherwise be activated by the loss of surface class I (16); on
the basis of this hypothesis, m4/gp34 has been referred to as
an “NK decoy.” However, until now there has been no ev-
idence for an effect of 
 
m4
 
 on any immune function.
In this paper, we show that 
 
m4
 
 cooperates with 
 
m152
 
 to
prevent recognition of virus-infected cells by CD8
 
 
 
 T
cells. 
 
m4
 
 is thus the third MCMV gene demonstrated to
interfere with the class I pathway of antigen presentation.
We show that 
 
m152
 
 has a differential effect on different
class I molecules, efficiently retaining D
 
b
 
 in a pre-Golgi
 
compartment but only partially retaining K
 
b
 
. To com-
pletely prevent recognition of virus-infected cells by three
K
 
b
 
-restricted CTL clones, both 
 
m4
 
 and 
 
m152
 
 were neces-
sary. In contrast, 
 
m4
 
 was not necessary to prevent recogni-
tion of infected cells by two D
 
b
 
-restricted CTL clones.
Thus 
 
m4
 
 and 
 
m152
 
 have complementary effects on differ-
ent class I molecules.
 
Materials and Methods
 
Generation of Mutant MCMVs.
 
Generation and characteriza-
tion of recombinants 
 
 
 
MS94.5 (with a deletion of ORFs 
 
m150
 
 to
 
165
 
), 
 
 
 
MC96.24 (with a deletion of ORF 
 
m152
 
), and rMC96.27
(revertant for 
 
 
 
MC96.24) were described previously (20, 21).
The recombinant 
 
 
 
m4-MC95.33, with an insertion of the
 
lacZ
 
 gene in place of the 
 
m4
 
 ORF, was generated by insertional
mutagenesis in eukaryotic cells as described previously (22), using
the plasmid construct pm4. The homologous recombining region
of pm4 was produced by flanking the 
 
lacZ
 
 gene with MCMV ge-
nomic sequences adjacent to the 5
 
  
 
(nt 2,739–3,250, left flank)
and 3
 
 
 
 (nt 4,041–4,737, right flank) ends of the ORF. Plasmid
DNA (pHindIIIA) (23) serving as MCMV genomic template and
primer pairs for the left flanking sequence (sense [5
 
 
 
-AA
 
CTC-
GAG
 
CATCACGGTGAACGATACCA], antisense [5
 
 
 
-TT
 
G-
GATCC
 
TGGAACAACGAATGAGACAGA]) and right flank-
ing sequence [sense (5
 
 
 
-AT
 
GCGGCCG
 
CTCGAACTTCA-
AACCGCTTAAGAG), antisense (5
 
 
 
-AA
 
CCGCGG
 
ACTTAT-
CGACGTACAATCCTGT)] were used in separate PCR reac-
tions to produce fragments with convenient restriction sites to
ligate to the 
 
lacZ
 
 gene (XhoI, BamHI and NotI and SacII, respec-
tively in bold). These fragments were inserted into corresponding
sites within the plasmid pIC4, which contains the 
 
lacZ
 
 gene un-
der control of the 
 
Rous sarcoma 
 
virus (RSV) promoter, SV40
poly(A), and flanking loxP sites (22). 30 fmol of linearized pm4
plasmid DNA was cotransfected with wt MCMV DNA (1.5 
 
 
 
g)
into NIH3T3 fibroblasts by calcium phosphate precipitation to
generate the recombinant virus 
 
 
 
m4-MC95.33. Recombinant
virus was isolated and plaque purified as described previously
(22). Correct recombinatorial mutagenesis within the genome of
 
 
 
m4-MC95.33 was confirmed by restriction enzyme analysis
(data not shown).
We have recently cloned the MCMV genome as an infectious
bacterial artificial chromosome (BAC) in 
 
Escherichia coli
 
 (24). The
MCMV-BAC plasmid pSM3fr contains the complete MCMV
genome and was transfected into permissive eukaryotic cells to
reconstitute the virus MW97.01 (wild-type; reference 25).
MW97.01 (wild-type), which contains the complete MCMV ge-
nome without any BAC sequence, has wild-type properties both
in vitro and in vivo, indicating that the MCMV genome can be
passaged in 
 
Escherichia coli
 
 without altering the properties of the
reconstituted viruses.
Recombinant MCMVs 
 
 
 
m4-MW99.03, 
 
 
 
m152-MW99.05,
and 
 
 
 
m4
 
 
 
m152-MW99.04 were generated by transfection of
the MCMV BAC plasmids p
 
 
 
m4, p
 
 
 
m152, and p
 
 
 
m4
 
 
 
m152,
respectively, into primary mouse embryo fibroblasts (MEFs) by
calcium phosphate precipitation technique as described previ-
ously (24). The MCMV BAC plasmid p
 
 
 
m4, which encodes an
exact deletion of the 
 
m4
 
 ORF (nt 3,270–4,067) by insertion of
the prokaryotic kanamycin resistance marker (kan
 
r
 
), was con-
structed using contiguous m4-kan sequence primer pairs: sense
(5
 
 
 
-TAATGATCTAGACGGCAATTTCTGTCTCATTCGT-
TGTTCCAGAGCGACGGATGGTACAAG) and antisense (5
 
 
 
- 
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TACTCAGAACACCGGAAAATGGTTTACTCAAGGGGA-
TTTTTATTTAGGGGGTTAGTTACT). The plasmid pACY-
C177 (New England Biolabs) served as template for the kanamy-
cin resistance marker. A linear DNA fragment containing
flanking homologies of 55 bp to the 
 
m4
 
 gene (nt 3,215–3,269 and
nt 4,068–4,123 in the MCMV genome) and the kan
 
r
 
 was gener-
ated by PCR amplification. This fragment was inserted into the
wild-type MCMV BAC plasmid pSM3fr (25) by homologous re-
combination in 
 
Escherichia coli
 
 to generate the MCMV BAC plas-
mid p
 
 
 
m4. The MCMV BAC plasmid p
 
 
 
m4
 
 
 
m152 was gener-
ated using contiguous 
 
m152
 
-zeocin primer pair PCR
amplification. The fragment containing flanking homologies of
60 bp to the 
 
m152
 
 gene (nt 21,0184–21,0243 and nt 21,0378 –
21,0437) and the zeocin resistance gene was generated using
sense (5
 
 
 
-GCTCGAGCGAGAGCACCCGACGATCTGAC-
ATTGTCCAGTGTGCCGGTCGCACGAACATCAGAAGT-
TCCTATTCTCTAGAAAGTATAGGAACTTCAACGTTT-
ACAATTTCGCCTGATGCG) and antisense (5 -TCACAA-
GCCGTGTCACCGCTCCACGTTTCACCGTCGTCGGT-
CTCCCGATCGCTAGCCTGAACAGAAGTTCCTATACT-
TTCTAGAGAATAGGAACTTCTGAAGTTTTAGCACGT-
GTCAGTCCT) primer pairs and the plasmid pZero1 (Invitro-
gen) as template. This fragment was inserted into the MCMV
BAC plasmid p m4 by homologous recombination in Escherichia
coli, generating plasmid p m4 m152.Plasmid p m4 m152 thus
carries exact deletions of the m4 and m152 ORFs and insertions
of the kanamycin resistance marker (in the case of m4) and the
zeocin resistance marker (in the case of m152) instead. Plasmid
p m152 was generated by homologous recombination between
pSM3fr and the m152-zeocin fragment. Correct mutagenesis was
confirmed by restriction enzyme and Southern blot analysis (data
not shown).
Recombinant MCMVs m4-Tn3514, m4Tn3516, and m4TnP
(with Tn1721 transposon insertions within the m4 gene or pu-
tative promoter, at nt 3,514, nt 3,516, and nt 3,099, respec-
tively) were reconstituted from recombinant MCMV-BAC
plasmids generated by direct transposon mutagenesis as de-
scribed previously (26, 27). The site of mutagenesis was con-
firmed by restriction enzyme analysis and sequencing (data not
shown).
The genomic organization of all MCMV mutants is shown
schematically in Fig. 1 A–C. Loss of m4/gp34 expression in the
BAC-derived recombinants was confirmed by Western blot anal-
ysis of cell lysates from infected NIH3T3 cells with the antiserum
m04-3 that detects m4/gp34 (see Fig. 1 D).
Experimental Animals. B6 mice were purchased from Simen-
son, and B10.A5R and B10.A2R from Jackson ImmunoResearch
Laboratories. Db /  mice (28) were a gift from Francois Lemon-
nier (Institut Pasteur, Paris, France).
Virus Stocks and Cell Culture. MEFs were grown from
Trypsin-digested, day 12–14 mouse embryos and used between
passages 3 and 6. Adult mouse fibroblast lines were generated
from ears of Db /  mice and from B6   129 backcrossed mice
and used between passages 3 and 6. NIH 3T3s (CRL-1658) and
Balb3T3s (CCL-163) were obtained from American Type Cul-
ture Collection. MEFs and 3T3s were maintained in DMEM
supplemented with 10% fetal (for MEFs, adult fibroblast lines,
and NIH3T3s) or newborn (for Balb3T3s) calf serum. Virus
stocks were generated by infecting subconfluent MEFs with low
passage seed stock at an multiplicity of infection (MOI) of 0.001.
Cells were then switched to DMEM plus 10% normal calf serum
until the monolayer became 100% infected. Stocks were har-
vested by scraping and sonication of cells. Titer of plaque form-
ing units was determined by serial dilution and agarose overlay
on Balb3T3s.
T Cell Line and Clones. B6 mice were infected intraperito-
neally with 5   104 PFU MCMV-Smith,  MS94.5, or
 MC96.24. Between 8 and 40 wk later, spleens were harvested.
10% of splenocytes were infected with MCMV (of the same
strain with which mice were infected) and returned to culture
with the remaining splenocytes. For polyclonal effectors, cultures
were used 5 d later in Cr-release assays. To derive CTL clones,
the cultures were cloned by limiting dilution on day 3 in the
presence of irradiated mixed allogeneic feeder splenocytes and 2
 g/ml concanavalin A (con A; Sigma-Aldrich). Clones were
maintained in cloning medium (RPMI medium with 10% FCS,
5    10 5 M 2-mercaptoethanol [Sigma-Aldrich], 1% condi-
tioned medium from IL-2–secreting cell line  63.653 [reference
29], and 10% conditioned medium from conA-stimulated rat
splenocytes), and restimulated with conA and irradiated mixed
allogeneic feeders each 10 d. Clones have been maintained in
culture for  12 mo. Clones were screened for antiviral function
based on their ability to specifically kill IFN- –boosted
 MS94.5-infected MEFs compared with uninfected MEFs.
Clones 3, 11, and 5 are from  MS94.5-infected mice (clone 5 is
from a different mouse than clones 3 and 11); clone 96 is from a
Smith-infected mouse; and clone 55 is from a  MC96.24-
infected mouse. Clones 3, 11, and 96 recognize different HPLC
fractions of peptides extracted from infected cells (data not
shown); clones 5 and 55 have not been tested against HPLC-
fractionated extracts.
Cytolytic T Cell Assays. MEF target cells were plated into 96-
well plates at 5,000 cells per well and treated with recombinant
mouse IFN-  (50 U/ml; Sigma-Aldrich) for 24 h, infected with
MCMV (at an MOI of 30 for Figs. 3 D and 4, and an MOI of 10
for all other Figures) unless otherwise indicated, and labeled with
51Cr (NEN Life Sciences Products) overnight, in the presence of
0.3 mg/ml phosphonoacetic acid (PAA; Sigma-Aldrich) to pre-
vent expression of viral late genes. CTL clones described here did
not kill MEF targets without IFN-  pretreatment (data not
shown). T cells were added at the indicated effector-to-target ra-
tios for 6 h, after which supernatants were harvested and assayed
for  -irradiation with a Topcount scintillation counter (Packard
Instrument Co.). Background Cr-release was determined by in-
cubating targets with medium alone, and total Cr release was
achieved by lysing targets with medium containing 2% Triton
X-100. The percentage of specific lysis was calculated as (experi-
mental cpm background cpm)/(total cpm-background cpm).
Each data point represents the mean of triplicate wells.
Antibodies. Serum 8010 (anti-p8) was generated by immuniz-
ing rabbits with synthetic peptide corresponding to exon 8 of Kb.
Sera 8142 and 8139 (anti-m4/gp34) were both generated as fol-
lows. Serum R123 against the cytoplasmic tail of m4/gp34 (16)
was used to precipitate m4/gp34 from MCMV (Smith)-infected
MEFs. After washing, the immune complex was suspended in
complete Freund’s adjuvant (Sigma-Aldrich) and used to immu-
nize rabbits subcutaneously. Rabbits were boosted first with im-
mune complex suspended in incomplete Freund’s adjuvant (IFA;
Sigma-Aldrich), and then by infection with recombinant vaccinia
virus expressing m4/gp34 (generated by recombination between
modified psc11 plasmid expressing the m4 gene and WR strain
vaccinia virus), and finally with recombinant m4/gp34 protein
purified from baculovirus, (the gift of Pamela Bjorkman, Califor-
nia Institute of Technology, Pasadena, CA) in IFA. Serum m04-3
used for Western blot analysis of m4/gp34 expression was gener-
ated by immunizing rabbits with synthetic peptide corresponding970 Complementary Functions of Murine Cytomegalovirus Immune-evasion Genes
to amino acids 34–48 of m4/gp34 (peptide sequence KEYKEK-
MKYRHSLGC). Monoclonal antibody 28.14.8S (HB-27;
American Type Culture Collection) was purified from hybrid-
oma supernatant.
Metabolic Labeling and Immunoprecipitations. B6 MEFs or adult
ear fibroblasts were pretreated with recombinant mouse IFN-  at
50 U/ ml for 24–48 h before infection. Without IFN- , unin-
fected MEFs do not express detectable amounts of class I. Al-
though infected cells express class I in the absence of IFN- , they
were also treated with IFN-  for the sake of consistency. Cells
were maintained in the presence of 0.3 mg/ml PAA after infec-
tion or mock infection. 1 h before the addition of metabolic la-
bel, cells were washed in PBS and placed in cysteine/methio-
nine-free DMEM (GIBCO BRL) supplemented with antibiotics,
and 5% FCS. Cells were then labeled with [35S]cysteine/me-
thionine ( 0.2  Ci/ml for long labeling periods and  0.5  Ci/
ml for pulse labels; NEN Life Sciences Products) for the time pe-
riods indicated. For pulse-chase experiments, cells were washed
with chase medium (DMEM supplemented with antibiotics,
glutamate, 10% FCS, and 1 mM L-cysteine and L-methionine;
Sigma-Aldrich) at the end of the labeling period. All lysis and
precipitation procedures were carried out at 4 C. Cells were
washed in the plates with PBS and lysed in NP-40 lysis buffer
(0.5% NP-40, 50 mM Tris-HCl, pH 7.6, 5 mM MgCl2). Just be-
fore use, lysis buffer was supplemented with protease inhibitor,
either 1 mM PMSF (Sigma-Aldrich) or Complete EDTA-free
protease-inhibitor cocktail according to the manufacturer’s direc-
tions (Boehringer Mannheim). Lysates were precleared by incu-
bation with at least 20  l of normal rabbit serum and 500  l of
10% suspension of fixed Staphylococcus aureus for 2 h, and centri-
fuged for 5 min at 15,000 g. Precleared lysates were then sub-
jected to specific immunoprecipitation as indicated in the Fig-
ures. Unless otherwise indicated, each aliquot of lysate received
 10  g of antibody plus 150  l of 5% protein A agarose suspen-
sion (Sigma-Aldrich). Immunoprecipitates were washed four
times in NET buffer (150 mM NaCl, 50 mM Tris, pH 7.5, 5
mM EDTA, and 0.05% NP40) containing 0.1% SDS. Samples
were digested with Endo Hf (New England Biolabs, Inc.) ac-
cording to manufacturer’s protocol, resuspended in reducing
sample buffer, and separated by SDS-PAGE on a 12.5% gel.
Quantitation of labeled protein was performed using a Molecular
Dynamics PhosphorImager.
Results
Construction of MCMV Mutants Lacking m4/gp34 Expres-
sion. MCMV mutants lacking m152/gp40 expression
have already been described previously (21). To compare
the functions of m4 and m152, we constructed mutant
MCMVs with targeted deletions of m4 and/or m152. The
process of generating mutant viruses may lead to accidental
mutations elsewhere in the genome, so in order to clearly
attribute a phenotype to the deleted gene, we have con-
structed five separate mutant viruses lacking m4, using three
different technologies (see Materials and Methods, Fig. 1,
and Table I).  m4-MC95.33 was made by homologous re-
combination between the viral genome and plasmid in
transfected cells (Fig. 1 A). Other mutants were reconsti-
tuted from BACs constructed by homologous recombina-
tion (Fig. 1 B) or transposon insertion (Fig. 1 C). The cor-
rect genomic structure of all BACs was confirmed by
restriction analysis and Southern blot analysis (data not
shown). Lack of m4/gp34 expression by all  m4 mutants
was confirmed by Western blot analysis (Fig. 1 D).
m4 Does Not Affect the Export of Kb over a 90-min Chase.
NK cells can lyse target cells with low cell surface class I;
thus viral functions that reduce cell surface class I in order
to protect against CTL recognition might render the in-
fected cells vulnerable to NK attack. We previously hy-
pothesized that m4/gp34 might serve to inhibit NK activ-
ity by rescuing some class I molecules from m152-induced
retention, thus increasing class I expression on the cell sur-
face (16). To test this hypothesis, we infected mouse em-
bryo fibroblast (MEF) cells with either wild-type virus or
the mutant virus  m4-MC95.33, at a range of multiplici-
ties of infection (MOIs), and measured the degree of Kb
export as indicated by the acquisition of Endoglycosidase H
(Endo H) resistance over a 90-min chase period. Fig. 2
shows that at any given MOI, infection with either  m4-
MC95.33 or wild-type virus caused comparable degrees of
Kb retention. In addition, at a fixed MOI of 5, we found
no significant difference between the amount of Kb that
was exported in wild-type or  m4-MC95.33-infected cells
at a range of timepoints after infection (data not shown).
We conclude that m4 does not affect the extent of Kb ex-
port in MCMV-infected fibroblasts.
m4/gp34 Expression Inhibits CTL Activity. We next in-
vestigated whether m4/gp34 expression could affect rec-
ognition of targets by class I–restricted CD8  CTLs. The
first experiments used polyclonal CTLs from spleens of
MCMV-infected C57BL/6 (B6) mice restimulated in
vitro with virus. Fig. 3 A shows one such experiment.
There was minimal specific lysis of targets infected with
wild-type MCMV, but strong CTL activity against targets
infected with  MS94.5, which lacks m152. Thus in wild-
type infection the combined effects of the immune-eva-
sion genes were able to completely abrogate recognition;
however, a virus lacking m152 was readily detected.
There was also significant killing of targets infected with
 m4-MC95.33, demonstrating that m4, in addition to
m152, contributes to immune evasion from polyclonal
CTLs.
To investigate this phenomenon further, we generated a
panel of MCMV-specific CTL clones from mice infected
with either wild-type MCMV or two mutant MCMV vi-
ruses lacking m152. The antigens recognized by these
clones have not yet been identified, but they are all ex-
pressed in the early phase of MCMV gene expression (data
not shown). Remarkably, none of these clones were able to
lyse cells infected with wild-type virus; this included clone
96 which was generated from a mouse infected with wild-
type virus. However, all the clones recognized targets in-
fected with viruses lacking m152 (Fig. 3 B–D), confirming
the importance of this immune-evasion gene. Next we
tested whether the clones could recognize viruses lacking
m4 but expressing m152. Fig. 3 B shows an experiment us-
ing  m4-MC95.33, and Fig. 3 C shows an experiment us-
ing   m4-MW99.03. Both m4 deletion mutants, which
were independently constructed using different techniques,971 Kavanagh et al.
were recognized, whereas the wild-type virus was not.
These results were extended in the assay shown in Fig. 3 D,
in which the three m4 deletion mutants generated by trans-
poson insertion, m4Tn3514, m4Tn3516, and m4TnP,
were tested for recognition by three different clones. All
three mutants were recognized by clones 11 and 96, consis-
tent with the previous results. However, we noted that
none of the three mutants was recognized by clone 3.
The results seen with five independent m4 deletion mu-
tants led us to conclude that the observed phenotype is in-
deed due to the functional deletion of the m4 gene. These
results demonstrate for the first time that m4, like m152 and
m6, acts as a viral immune-evasion gene. However, the re-
sults seen with clone 3 demonstrate that deletion of m4 is
not by itself sufficient to permit MCMV recognition by
some CTL clones.
Clone 3 Does Not Recognize an Epitope within m4/gp34.
We wondered why only some CTL clones could recognize
cells infected with m4 deletion mutants. m4/gp34 provides
an epitope recognized by MCMV-specific CTLs from
Balb/c mice (30). One possible explanation for inability of
clone 3 to recognize m4 deletion viruses was that the
epitope recognized by clone 3 could be derived from m4/
gp34 itself. Since clone 3 can respond to viruses lack-
ing  m152, we constructed a new virus ( m4 m152-
MW99.04) lacking both m152 and m4. Fig. 4 shows that
this virus was readily detected by clone 3, indicating that
the epitope recognized by clone 3 is not contained within
m4/gp34.
m4 Is Necessary for Evasion from Kb- but not Db-restricted
CTL Clones. To further analyze why some clones were
able to recognize m4 deletion mutants and others not, we
determined the restriction element used by five MCMV-
specific CTL clones. MEFs from B10A.2R (KkDb) or
B10A.5R (KbLdDd) mice were infected with MCMV-
 MS94.5 and used as targets in CTL assays. Fig. 5 A shows
that clones 3 and 55 are restricted by Db, and clones 5, 11,
and 96 are restricted by Kb. These five clones were next
tested for their ability to lyse targets infected with m4 dele-
tion mutants. The results are shown in Fig. 5 B. All three
Kb-restricted clones were able to lyse targets infected with
m4 deletion mutants, indicating that m4 expression was
Figure 1. Construction of mutant viruses. (A) Sche-
matic representation of the 230-kb linear MCMV ge-
nome. HindIII digestion generates 16 fragments, desig-
nated A–P by size, organized in the genome as shown
(not to scale). Sequencing of the complete genome
(reference 17) revealed 170 potential open reading
frames, numbered from the left to the right hand end
of the genome, 1–170. ORFs with homology to
HCMV genes are given a capitalized M (e.g. M84), and
MCMV genes without recognized homology are de-
noted by a lower case m (e.g. m4). Also shown are the
positions of m4 and m152 within the genome, and the
strategy for generation of the m4 deletion mutant
 m4-MC95.33 by insertion of the lacZ gene. (B) Gen-
eration of BAC mutants by insertional mutagenesis.
Kanamycin and zeocin resistance genes were inserted
into the pSM3fr BAC plasmid as shown to replace the m4
and m152 ORFs, respectively. Transfection into permis-
sive cells generated the mutant viruses  m4-MW99.03,
 m4 m152-MW99.04, and  m152-MW99.05. (C)
Generation of BAC mutants by transposon mutagenesis.
(D) Western blot analysis using anti-m4/gp34 serum
m4-03 of lysates from cells infected with the viruses
shown. All viruses were used at the same MOI and all
infected cells showed comparable cytopathic effect.972 Complementary Functions of Murine Cytomegalovirus Immune-evasion Genes
necessary for complete immune evasion from these clones.
In contrast, the two Db-restricted clones did not recognize
the  m4 deletion mutants, indicating that the other im-
mune-evasion genes were sufficient to prevent MCMV-
specific killing by these clones.
MCMV Differentially Inhibits Maturation of Different Class I
Molecules. The difference between Kb- and Db-restricted
CTL clones suggested that Kb and Db might show different
sensitivities to the effects of the immunomodulatory genes.
The three Kb-restricted clones can lyse targets infected with
virus containing a single deletion of either m152 or m4, in-
dicating that m152 is necessary to prevent antigen presenta-
tion by Kb but is not sufficient for this task in the absence of
m4. In contrast, the two Db-restricted clones can lyse in-
fected cells if m152 is deleted, but are unable to detect virus
in which m4 is deleted while m152 remains. This suggested
that Db might be more susceptible to the activity of m152
than Kb. m152 inhibits antigen presentation by retaining
class I molecules in the ERGIC. Therefore, we performed
a pulse-chase experiment comparing the relative rates of
export of Kb and Db in MCMV-infected cells. B6 MEFs
were pulsed with [35S]methionine for 15 min and chased
Table I. Viruses Used in This Paper
Virus Method Genotype Insertion
Smith strain natural isolate wild-type none
MW97.01 BAC  derived wild-type none
 MS94.5 mutagenesis in cellsa  ORFs 150-165 lacZ
 MC96.24 mutagenesis in cells  m152 none
rMC96.27 mutagenesis in cells wild-type, revertant of  MC96.24 none
 MS94.7 spontaneous mutant  ORFs 1-17 none
 m4-MC95.33 mutagenesis in cells  m4 (nt 3250-4041) lacZ
 m4-MW99.03 BAC/recombinationb  m4 (nt 3270-4067) kanr
m4Tn3514 BAC/transposonc m4 disrupted Tn1721 into m4 at nt 3514
m4Tn3516 BAC/transposon m4 disrupted Tn1721 into m4 at nt 3516
m4TnP BAC/transposon putative m4 promoter disrupted Tn1721 into putative m4 promoter at nt 3099
 m4+m152-MW99.04 BAC/recombination  m4+m152
(nt 3270-4067 and 210244-211377 kanr/zeocinr
 m152-MW99.05 BAC/recombination  m152
(nt 210244-211377) zeocinr
The methods used to create mutant MCMVs are described in Materials and Methods.
aRecombination between plasmid and wild-type MCMV in transfected cells.
bHomologous recombination in Escherichia coli between MCMV BAC and insert.
cTransposon-mediated mutagenesis of MCMV BAC in Escherichia coli.
Figure 2. m4 does not counteract the effects of m152 on Kb. (A) Immunoprecipitation of Kb and m4/gp34 from MEFs infected with increasing doses
of wild-type (Smith) or  m4-MC95.33 MCMV. Cells were infected at the indicated MOI for 5 h, labeled for 30 min with [35S]methionine, and chased
for 90 min with unlabeled methionine. Cells were lysed in NP-40 lysis buffer. Kb was immunoprecipitated with anti-p8 and m4/gp34 with serum 8142.
All samples were treated with Endo H. The positions of bands corresponding to Endo H-resistant (R) and -sensitive (S) molecules are indicated. (B)
Quantitation of Kb export. The amount of Endo H-sensitive (retained) and Endo H-resistant (exported) Kb was determined with phosphorimage analysis
of the gel shown in A. The degree of export is calculated as the percentage of export equals (resistant)/(resistant plus sensitive).973 Kavanagh et al.
for 1, 2, or 4 h. Kb and Db were immunoprecipitated from
the same lysates and the respective degree of maturation
was determined by Endo H digestion. Fig. 6 A shows that
in uninfected cells, both Kb and Db became Endo H-resis-
tant over the chase period, although the maturation of Db
was slower than maturation of Kb. In contrast, in infected
cells almost all Db was retained in an Endo H-sensitive
form over the entire 4 h, while  50% of the Kb protein
was exported and matured within 2 h. We also noted that
the m4/gp34 coprecipitating with the class I molecules dis-
played a parallel pattern. There was little m4/gp34 associ-
ated with Db, and all Db-associated m4/gp34 was Endo
H-sensitive; in contrast, there was a significant amount of
Kb-associated m4/gp34, which also became 50% Endo
H-resistant by 2 h of chase, and nearly 100% Endo H-resis-
tant by 4 h.
Because of the slower rate of maturation of Db in unin-
fected cells, we wondered whether the effect of m152
might simply be a general retardation of the maturation of
both molecules with no eventual effect on the relative
steady-state degree of export. To address this we labeled
cells continuously from 2 to 16 h after infection, and se-
quentially immunoprecipitated first Kb and then Db from
the same lysates. Fig. 6 B shows that whereas all the Db
from infected cells remained Endo H sensitive, the majority
of Kb acquired Endo H resistance. Again, a parallel matura-
tion pattern of class I–associated m4/gp34 was observed.
The results shown in Fig. 6 A and B are typical of a series
of similar experiments in which Db retention was always
nearly complete, while Kb retention, although variable, was
always less. Thus, in infected fibroblasts relatively little Db
is available to reach the cell surface, but a large portion of
Kb, some of which is m4/gp34-associated, eventually passes
through the Golgi to the cell surface.
The observed differential effects of MCMV infection on
Kb and Db indicate that these molecules are differently af-
fected by m152. Although a sustained interaction between
m152/gp40 and class I has not been demonstrated, we rea-
soned that Kb might be able to escape retention because of
competition by Db (which is fully retained) for a limiting
amount of m152/gp40. To test this possibility we deter-
mined the extent of export of Kb molecules in infected fi-
broblasts from mice with a targeted deletion of Db. If com-
petition for m152/gp40 were the cause of the differential
retention of Kb and Db, then in the absence of Db, Kb
should be fully retained during the 3-h chase period. How-
ever, as shown in Fig. 6 C, even in the absence of Db, a sig-
nificant amount of Kb escaped m152-mediated retention.
We conclude that the difference in susceptibility to m152 is
intrinsic to the individual class I proteins and not due to in-
termolecular competition.
Discussion
In this paper we have provided the first evidence of a
function for the MCMV gene m4. Previous discussion of
the function of m4 has been limited to speculation, based
on its biochemical association with MHC class I molecules.
We have demonstrated here that expression of m4 by
MCMV-infected target cells protects those targets from
killing by some class I–restricted CTL clones. Thus m4
joins m152 and m6 as the third MCMV CTL-evasion gene.
Furthermore, the mechanism of action of m4 is likely to be
entirely novel, since all previously described viral CTL-
evasion genes have had the effect of reducing class I surface
expression, by inhibition of class I transport, removal of
Figure 3. m4 is an immune-
evasion gene. Polyclonal CTL or
CTL clones were tested for their
ability to lyse B6 MEFs infected
with the viruses shown. Targets
were pretreated with IFN-  and
infected overnight in the pres-
ence of PAA. (A) Polyclonal
CTLs were tested against
∆MS94.5 (lacking ORFs 150–
165),  m4-MC95.33, and wild-
type MCMV (Smith). (B–D)
MCMV-specific CTL clones
were tested against Smith or the
wild-type BAC virus MW97.01
and various m4 deletion mutants, as follows. (B)  m4-MC95.33,  MS94.7 (lacking ORFs 1–17),  MS94.5, and Smith. (C)  m4-MW99.03,  MS94.5,
and Smith. (D)  m152-99.05, MW97.01 (wild-type), and three m4 deletion viruses: m4Tn3514, m4Tn3516, and m4TnP.
Figure 4. The antigen recognized by clone 3 is not m4/gp34. B6
MEF targets were infected with MCMV MW97.01 (wild-type),
m4Tn3516, m4TnP,  m4 m152-MW99.04, or  m152-MW99.05.
The difference in degree of lysis of targets infected with  m152 and
 m4 m152 is not reproducible.974 Complementary Functions of Murine Cytomegalovirus Immune-evasion Genes
Figure 5. m4 is necessary for evasion
from Kb- but not Db-restricted CTL clones.
(A) Two MCMV-specific clones are Db-
restricted and three are Kb-restricted. The
class I–restriction elements used by five
CTL clones, derived from MCMV-infected
B6 mice, were determined by testing the
ability of each clone to lyse fibroblasts from
B10A.2R (KkDb) or B10A.5R (KbLdDd)
mice. Fibroblast targets were either unin-
fected or infected with MCMV  MS94.5.
(B) Kb- but not Db-restricted clones respond
to MCMV lacking m4. The five CTL
clones were tested for ability to lyse of B6
MEFs infected with the indicated viruses.
Figure 6. Differential effects of
MCMV infection on maturation of
different class I proteins. (A) In a 4-h
pulse chase, Kb partially escapes from
MCMV-mediated retention, but Db
does not. B6 MEFs were infected
with MCMV (Smtih) for 5 h, pulsed
with [35S]methionine/ cysteine for
15 min, and chased for the indicated
time period. Kb and Db were se-
quentially immunoprecipitated from
the same lysates. (B) The differential
effect is also apparent over a 14-h la-
beling period. Fibroblast lines from
adult H-2b (B6   129) mice were
infected with MCMV (Smith). Cells
were continuously labeled with
[35S]methionine/cysteine from 2–16 h
after infection. Kb and Db were se-
quentially immunoprecipitated from
the same lysates. (C) Escape of Kb
from the effects of m152 is not due
to competition between Kb and Db.
Fibroblasts from Db /  mice were
infected with the indicated virus,
pulsed for 30 min, and lysed imme-
diately or chased for 3 h. The posi-
tions of bands corresponding to
Endo H-resistant (R) and -sensitive
(S) molecules are indicated.975 Kavanagh et al.
class I from the cell surface, or TAP blockade. In contrast,
we show here that while m4 does not inhibit Kb export
from the ER, (Fig. 2), it significantly inhibits killing of
MCMV-infected targets by Kb-restricted clones. This inhi-
bition is demonstrated in Fig. 3, where we show that MEF
targets infected with wild-type MCMV were not recog-
nized by CTLs, while targets infected with mutant viruses
lacking m4 were recognized to a significant extent. Thus
m4 inhibits CTL recognition of infected targets even
though they express significant amounts of mature Kb (Figs.
2 and 6, and reference 16).
The mechanism by which m4 inhibits CTL recognition
is not yet known. We have found that between 50 and
70% of mature Kb synthesized over the course of MCMV
infection coprecipitates with m4/gp34 in the presence of
0.5% NP40. In addition, immature Kb forms complexes
with m4/gp34 which are observed in lysates made with the
weaker detergent digitonin (1a). Thus we imagine two
mechanisms by which m4 may inhibit CTL activity, either
or both of which may be operative: ER-localized m4/
gp34 may alter peptide-loading of Kb, and/ or surface-
exposed m4/gp34 may alter class I recognition by the
TCR or CD8. We are currently in the process of identify-
ing peptide epitopes recognized by MCMV-specific CTLs,
which will facilitate the investigation of these possibilities.
In addition to demonstrating the immune-evasive func-
tion of m4, our results describe, for the first time, the func-
tional interaction of multiple immune-evasion genes in
cells infected with a herpes virus. It has been a longstanding
puzzle why CMVs should encode multiple genes (at least
four in HCMV and at least three in MCMV) which all
have the general effect of reducing class I–restricted antigen
presentation. Multiple genes could interact in any of several
ways, ranging from complete redundancy to cooperation
or synergy. Many previous papers describing viral immune-
evasion genes have relied on transfected cells overexpress-
ing single viral genes, and thus can shed no light on this
question; however, some possibilities have been discussed
in the case of HCMV. Ahn et al. raised the hypothesis of
synergy (8). They observed that the HCMV gene US3 is
expressed earlier in the viral cycle than US2 and US11, and
thus might augment the function of the latter genes by re-
taining class I. Machold et al. proposed another reason for
HCMV to encode both US2 and US11, which both have
the effect of targeting class I for degradation by the protea-
some. They suggested these genes might preferentially tar-
get different class I molecules (31). Using cell lines trans-
fected with either US2 or US11, and infected with vaccinia
viruses encoding various alleles of murine class I genes, they
noted that US2 degraded only a subset of the class I mole-
cules that were degraded by US11. However, since no
functional assays were done, and only murine class I was
tested (while HCMV infects only humans), the biological
relevance of the finding was unclear.
Here we have employed a biologically relevant system,
using MCMV-infected primary cells to assess the effect of
m4 and m152 on antigen presentation to MCMV-specific
CTLs. The first clear conclusion from the results reported
here is that the genes are not redundant. Deletion of either
m152 or m4 allows detection of infected cells by Kb-
restricted CTL clones. Thus a contribution from both of
these genes (and perhaps also from m6 which was not tested
here) is necessary for complete abrogation of antigen pre-
sentation in this experimental system. At present we have
no data to indicate whether the effects of m4 and m152 are
synergistic or merely additive. We also report a differential
effect of the immune-evasion genes on antigen presenta-
tion by two different class I molecules, Kb and Db. We
found that while expression of both m152 and m4 was nec-
essary for complete abrogation of antigen presentation to
three Kb-restricted clones, expression of m152, but not of
m4, was required to completely block antigen presentation
to two Db-restricted clones (Fig. 5).
These observations, using a limited number of CTL
clones, suggested that Db would be more affected by m152
than Kb. This prediction was confirmed by our biochemi-
cal analysis of class I assembly in MCMV-infected fibro-
blasts. Fig. 6 demonstrates that the combined effects of
m152 and m6 were insufficient to completely prevent mat-
uration of Kb. During a 120-min chase,  50% of newly
synthesized Kb molecules became mature (i.e., were ex-
ported past the medial Golgi). In contrast, almost no Db
became Endo H-resistant  4-h chase. Furthermore, we
note that the mature (Endo H-resistant) Kb molecules had
significant amounts of m4/gp34 associated with them,
while there was relatively little m4/gp34 associated with
Db. Thus, the class I molecule which escapes from the ef-
fects of m152 and m6, Kb, is preferentially targeted by m4.
The difference in retention of Kb and Db is even more
strikingly evident over the course of a 16-h labeling pe-
riod, as shown in Fig. 6 B. The CTL assays monitored an-
tigen presentation by a small subset of total class I, that
which was loaded with cognate peptides. The biochemical
experiments, on the other hand, monitor the potential for
antigen presentation of all the class I synthesized during in-
fection. The almost complete retention of Db due to m152
contrasts with the significant export of Kb. This fully sup-
ports the prediction, based on the CTL assays, that Kb
would need m4 as a “backup” mechanism for m152 in or-
der to fully inhibit antigen presentation, whereas Db may
not. We conclude that m4 complements the function of
other MCMV immune-evasion genes.
These observations raise some interesting questions re-
garding the coevolution of viruses and the immune system.
Class Ia loci are both polygenic and highly polymorphic,
and it is generally accepted that this diversity reflects evolu-
tionary selection for the ability to present a broad array of
different peptides. In addition to differences in peptide
binding, however, different class Ia molecules also assemble
at different intrinsic rates (Fig. 6 and references 32–34) and
with different dependence on various chaperones (35–37);
the evolutionary implications of these differences are less
clear. We have now shown that Kb and Db have differential
susceptibility to the effects of MCMV m152, and that the
virus requires a “backup gene”, m4, in order to achieve
complete protection against CTL lysis in vitro. This raises976 Complementary Functions of Murine Cytomegalovirus Immune-evasion Genes
the possibility that intrinsic differences in the assembly be-
havior of Kb and Db may reflect evolutionary pressure to
avoid the effects of viral genes such as m152. Such a tit-for-
tat evolutionary model is already widely accepted in the
case of NK cells, in which the “missing self” response is be-
lieved to have evolved to counteract virally induced class I
downregulation; in turn, CMVs encode genes (the signal
sequence of HCMV UL40 [references 38 and 39], MCMV
m144 [reference 40], and perhaps HCMV UL18 [reference
41]) which inhibit NK activity.
We have provided evidence suggesting that one function
of the multiplicity of immune-evasion genes of MCMV is
to provide more effective coverage of the diverse class I
molecules present in natural outbred host populations. This
does not preclude the possibility that some of the other hy-
pothetical advantages discussed previously may also be op-
erative. It is interesting to note that the CTL evasion genes
of both MCMV and HCMV are encoded within families
of related membrane glycoproteins which are not essential
for virus replication in vitro, and which contain many
genes whose functions have not yet been identified. There
is much still to be learned about the ways that CMVs ma-
nipulate the cellular immune response, and the ways that
the multiple genes interact to provide selective advantage
for the virus.
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